YBX3 and neoplasm: Our research, however, found that, across 39 TCGA databases, YBX3 is associated with tumor infiltration of all kinds of immune cells only in LIHC, indicating that YBX3 might enhance tumor immune evasion and progression of LIHC through dysfunctional T-cell phenotypes.